INFORMED AND PROTECTED. TRAINING COURSE FOR TRANS* PEOPLE
On September 13-14, 2022, capacity building training was held for trans* people by New Generation Humanitarian NGO (NGNGO).
The goal of the training was to raise the awareness of trans* about the importance of HIV prevention and testing, HIV prevention methods, ways of transmission, as well as to enhance their legal awareness by providing knowledge in the field of the right to health, the right to be free from stigma and discrimination.
The training was launched with the presentation of the topic of “The importance of HIV prevention and testing”. Trainer Hmayak Avetisyan gave detailed information about HIV and AIDS, transmission ways, and prevention methods to the participants. The trainer also spoke about the sexually transmitted infections, prevention methods, as well as informed the participants about NGNGO HIV testing and prevention services, availability of referrals for STIs screening and treatment, screening for HCV and HBV, for pre-exposure and post-exposure prophylaxes for HIV, etc.
On the second day of the training, lawyer Shushan Khnkoyan introduced the topic of the Right to Health to the participants, presenting them the mechanisms of domestic and international protection, the rights of RA citizens to health, the RA Law “on medical aid and services”, the RA Law “on Prevention of the disease caused by the human immunodeficiency virus”, the rights and obligations of people living with HIV.
Next, the trainer presented the topic of Stigma and Discrimination”, introducing the participants to the definition of stigma and discrimination, manifestations and types of discrimination, domestic and international legislation prohibiting discrimination.
The training went on in an atmosphere of active discussions, questions and answers, including theoretical lectures and practical workshops, team exercises.
The training course was organized within the framework of the project of “Support to the Armenian State Strategic Program for HIV/AIDS Prevention” implemented with financial support of Gilead Sciences Inc․